Takahide Taguchi
Department of Otorhinolaryngology
Head and Neck Surgery
Yokohama City University School of Medicine
Kanazawa-ku
Japan
Name/email consistency: high
- Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Taguchi, T., Tsukuda, M., Mikami, Y., Matsuda, H., Tanigaki, Y., Horiuchi, C., Nishimura, G., Nagao, J. Auris. Nasus. Larynx (2009)
- Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib. Taguchi, T., Tsukuda, M., Imagawa-Ishiguro, Y., Kato, Y., Sano, D. Oncol. Rep. (2008)
- Concurrent chemoradiotherapy with carboplatin and uracil-ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx. Taguchi, T., Tsukuda, M., Mikami, Y., Horiuchi, C., Ishitoya, J.I., Katori, H. J. Laryngol. Otol (2006)
- Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx. Taguchi, T., Tsukuda, M., Mikami, Y., Matsuda, H., Horiuchi, C., Yoshida, T., Nishimura, G., Ishitoya, J., Katori, H. Acta Otolaryngol. (2006)
- Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas. Taguchi, T., Kato, Y., Baba, Y., Nishimura, G., Tanigaki, Y., Horiuchi, C., Mochimatsu, I., Tsukuda, M. Oncol. Rep. (2004)